← Back
$MBX All transactions

MBX Biosciences, Inc.

A

$ Value

$0

Shares

Price

$0

Filed

Apr 22

Insider

Name

Hoerter Steven L.

Title

CIK

0001533451

Roles

Director

Transaction Details

Transaction Date

2025-11-22

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2025 totals no more than $1,000,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718. | The grant will vest in equal monthly installments over a one-year period from November 6, 2025, subject to the non-employee director's continued services to the Company.

Filing Info

Accession No.

0001193125-26-168530

Form Type

4/A

Issuer CIK

0001776111

Hoerter Steven L.'s History

Date Ticker Type Value
2026-01-02 ORIC A $0
2025-11-22 MBX A $0
2025-11-22 MBX A $0
2025-11-06 MBX A $0
2025-11-06 MBX A $0
2025-10-17 MBX $265K
2025-06-18 CCCC A $0
2025-06-05 MBX A $0

Other Insiders at MBX (90d)

Insider Bought Sold Last
Hoerter Steven L. 2025-11-06
Hawryluk P. Kent
President & CEO
2026-02-26
Bartram Richard
Chief Financial Officer
2026-02-02
Azoulay Salomon
Chief Medical Officer
2026-02-02